Semaglutide and Weight-loss
Semaglutide, a medication initially developed to manage diabetes, has shown potential as a weight loss aid. It works by decreasing appetite, thus reducing calorie consumption. The normal dosage for weight-loss is administered weekly.In a stage 3 medical trial performed in 2021, it was found that administering a weekly 2.4 milligram dosage of Semaglutide resulted in noteworthy weight reduction.
Wegovy: The First Once-Weekly Medication
Under the brand Wegovy, Semaglutide has received FDA approval for the long-term management of weight. This medication, which is taken once a week, is the very first in its class to be approved by the FDA for persistent weight management.While the drug can help in weight reduction, it ought to be used alongside modifications to diet plan and workout for the best results. The FDA recommends losing 5% to 10% of body weight through diet and workout as it can have substantial health advantages.